HomeCompareJNJ vs MA

JNJ vs MA: Dividend Comparison 2026

JNJ yields 2.14% · MA yields 0.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MA wins by $466.8K in total portfolio value
10 years
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →
MA
MA
● Live price
0.64%
Share price
$494.00
Annual div
$3.15
5Y div CAGR
91.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$497.2K
Annual income
$341,049.48
Full MA calculator →

Portfolio growth — JNJ vs MA

📍 MA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJNJMA
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JNJ + MA cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JNJ pays
MA pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
MA
Annual income on $10K today (after 15% tax)
$54.20/yr
After 10yr DRIP, annual income (after tax)
$289,892.06/yr
At 15% tax rate, MA beats the other by $285,854.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JNJ + MA for your $10,000?

JNJ: 50%MA: 50%
100% MA50/50100% JNJ
Portfolio after 10yr
$263.8K
Annual income
$172,899.68/yr
Blended yield
65.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MA right now

JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
MA
Analyst Ratings
1
Strong
51
Buy
12
Hold
Consensus: Buy
Price Target
$667.33
+35.1% upside vs current
Range: $610.00 — $739.00
Altman Z
9.7
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JNJ buys
8
MA buys
8
PoliticianChamberTickerTypeAmountDate
Sheldon Whitehouse🏛 Senate$MA▼ Sell$1,001 - $15,0002026-02-23
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Markwayne Mullin🏛 Senate$MA▲ Buy$50,001 - $100,0002025-12-29
Markwayne Mullin🏛 Senate$MA▲ Buy$50,001 - $100,0002025-12-29
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJNJMA
Forward yield2.14%0.64%
Annual dividend / share$5.20$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR28%91.8%
Portfolio after 10y$30.5K$497.2K
Annual income after 10y$4,749.88$341,049.48
Total dividends collected$15.6K$463.2K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyBuy
Analyst price target$228.73$667.33

Year-by-year: JNJ vs MA ($10,000, DRIP)

YearJNJ PortfolioJNJ Income/yrMA PortfolioMA Income/yrGap
1← crossover$10,594$274.49$10,822$122.30$228.00MA
2$11,294$360.69$11,817$237.26$523.00MA
3$12,133$476.91$13,109$464.38$976.00MA
4$13,156$635.42$14,950$923.39$1.8KMA
5$14,432$854.61$17,884$1,887.66$3.5KMA
6$16,056$1,162.76$23,183$4,047.78$7.1KMA
7$18,175$1,604.53$34,212$9,405.89$16.0KMA
8$21,009$2,252.68$61,488$24,880.97$40.5KMA
9$24,911$3,229.73$145,949$80,157.01$121.0KMA
10$30,458$4,749.88$497,215$341,049.48$466.8KMA

JNJ vs MA: Complete Analysis 2026

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

MAFinancials

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers other payment-related products and services. The company offers integrated products and value-added services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; prepaid programs and management services; commercial credit and debit payment products and solutions; and payment products and solutions that allow its customers to access funds in deposit and other accounts. It also provides value-added products and services comprising cyber and intelligence solutions for parties to transact, as well as proprietary insights, drawing on principled use of consumer, and merchant data services. In addition, the company offers analytics, test and learn, consulting, managed services, loyalty, processing, and payment gateway solutions for e-commerce merchants. Further, it provides open banking and digital identity platforms services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus. Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.

Full MA Calculator →
📬

Get this JNJ vs MA comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JNJ vs ABBVJNJ vs MRKJNJ vs PFEJNJ vs BMYJNJ vs LLYJNJ vs SCHDJNJ vs JEPIJNJ vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.